Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Top Clin Nutr. 2011 Jan-Mar;26(1):45–56. doi: 10.1097/TIN.0b013e3181faba4c

Nutritional Intake in Adult Hemodialysis Patients

Susan Stark 1, Linda Snetselaar 2, Beth Hall 1, Roslyn A Stone 3,4, Sunghee Kim 3,4, Beth Piraino 1, Mary Ann Sevick 1,3,4,5
PMCID: PMC4122303  NIHMSID: NIHMS498019  PMID: 25104876

Abstract

Background

Research pertaining to the nutritional intake of hemodialysis patients is limited.

Purpose

Describe the nutritional quality of foods consumed by hemodialysis patients and variation by day of the week.

Methods

Dietary recalls were obtained from 22 hemodialysis patients and analyzed using the Nutrition Data System for Research.

Results

Few statistically significant differences were found by day of the week, but several dietary deficits were noted.

Conclusion

The data suggest poor intake of calories, protein, and several vitamins and minerals, as well as excess sodium consumption, but little variation by day of the week. Additional research is needed.

Keywords: renal dialysis, sodium, dietary, cross-sectional studies, nutritional deficits

Introduction

Significant lifestyle changes are required of thrice weekly in-center hemodialysis (HD) patients, including self-administration of numerous medications, fluid and dietary restrictions, and regular attendance at dialysis sessions. One of the most challenging components of dialysis treatment is the need to adhere to a complicated and fairly restrictive dietary regimen.15

Controlling sodium and fluid intake are important components of the HD diet. Extra-cellular volume expansion (which is controlled primarily by limiting dietary intake of sodium) is the main pathophysiologic determinant of hypertension in HD patients.6 Hypertension occurs in an estimated 72–90% of dialysis patients79 and is an important predictor of survival.10 In addition to the cardiovascular effects of fluid volume overload, patients with substantial interdialytic weight gains require increased ultrafiltration during dialysis, which has been shown to cause intradialytic hypotension and post-dialysis symptoms.11

Hyperphosphatemia is an important factor in the development of cardiovascular calcification, cardiac disease, and death in patients with chronic renal failure,12 and a major factor contributing to renal osteodystrophy.13 Phosphates are not adequately removed by dialysis, and must be controlled through either oral intake of phosphorus binders, reduced dietary phosphorus intake, or both. The intake of binders is difficult for many patients because of the large number of capsules or tablets that must be taken with every meal or snack. Thus, a combination of dietary restriction and phosphorus binders is critical to control hyperphosphatemia.

In addition, as glomerular filtration falls, patients must limit their intake of some fresh fruits and vegetables to prevent hyperkalemia between dialysis treatments. This is particularly critical in patients on intermittent, three times weekly HD. About 10% of patients on HD exhibit serious hyperkalemia.14 Hyperkalemia is responsible for 24% of emergency dialysis treatments15 and is likely one cause of sudden death in HD patients.

As kidney disease progresses many patients develop a decreased desire for food which often persists after they begin dialysis treatments. In the face of multiple dietary restrictions and less than optimal appetite, HD patients are predisposed to protein-energy malnutrition. Maintaining adequate nutritional intake is a key counseling concern for renal dietitians. Recent reports suggest that reduced protein energy intake is related to inappropriate dietary restrictions, disruption of meals by the dialysis schedule, fatigue, anorexia, taste alterations, and decreased appetite.1619 Three studies have shown greater dietary energy deficits on dialysis treatment days compared to nondialysis treatment days.17,1920 The most comprehensive of these studies involved 1,901 participants of the Hemodialysis Study prospective multicenter clinical trial. In this trial, dietary energy intake was 1.02 kcal/kg/day less (p<0.001), and dietary protein intake was 0.06 g/kg/day less (p<0.001), on dialysis treatment days than on nondialysis treatment days.17 To our knowledge, no studies have compared the nutritional quality of food consumed on dialysis treatment days to that on nondialysis treatment days. Finally, while diminished appetite may result in reduced food intake on dialysis days, because HD treatments are time consuming and many patients experience fatigue following treatment, we surmised that on dialysis days they would consume a greater number of convenience foods having lower nutritional quality and higher concentrations of sodium. To our knowledge, no studies have examined the sodium concentration of foods consumed on dialysis days (e.g. the proportion of grams of sodium to total grams of food consumed).

The purpose of the current report is to describe the nutritional quality of foods consumed and the variation of nutritional intake by type of day (weekday or weekend, and whether or not it is a dialysis treatment day) in a cohort of maintenance HD patients.

Methods

BalanceWise-HD is a randomized clinical trial designed to develop and pilot test an intervention to reduce dietary sodium intake in maintenance HD patients.21 Personal digital assistant (PDA)-based dietary self-monitoring with BalanceLog® software was used to target problematic foods, with participants counseled to make dietary changes using concepts based in Social Cognitive Theory.22 The intervention is described elsewhere.21 The relevant baseline measures obtained from the participants in this pilot study are summarized in the current report.

Design

Participants were recruited from two dialysis centers located in Southwestern Pennsylvania. Only patients who were at least 18 years or older who had been receiving intermittent maintenance HD for at least 3 months were included. A 3-month minimum duration of HD prior to recruitment allowed for initial treatment stabilization and adjustment to the HD regimen. Patients were approached on the dialysis unit during regularly scheduled treatments by a dialysis center nurse, dietitian, or social worker, to solicit their interest in the study and obtain a HIPAA authorization. Those who signed the HIPAA authorization were further screened to exclude individuals who were (1) scheduled to receive a living donor transplant during the study period, (2) unwilling or unable to speak 1–2 times per week with a study dietitian about their diet, or (3) unwilling to record, on a regular basis, foods that they consumed. Participants were also screened to verify that they could (4) turn on the PDA used in the intervention, (5) see the PDA screen, and (6) use the stylus to navigate the PDA. Patients meeting the study inclusion criteria were administered the informed consent. Additional information was gathered to assure that the participant was (7) not considered by nursing staff to be terminally ill. Finally, (8) a Mini-Mental Status Exam was administered and patients with a score below 17 were excluded.23 The study protocol was approved by the IRB of the University of Pittsburgh.

Measures

Dietary intake was assessed via three unscheduled recalls during a two-week window prior to randomization. Unscheduled recalls can mitigate the potential for desirability response bias and/or actual changes in dietary patterns that could result from participants’ anticipation of a scheduled recall. To assess day-to-day variation in dietary intake, recalls were obtained on 3 types of days [one weekday dialysis day (WeekdayDD), one weekday nondialysis day (WeekdayNDD), and one weekend nondialysis day (WeekendNDD)]. To minimize burden, the investigators chose not to collect face-to-face recalls on nondialysis days (to avoid requiring participants to travel to a central study location), and chose not to collect telephone recalls on dialysis days (to avoid further burdening patients who commonly experience post-dialysis fatigue). Consequently recalls for the WeekdayNDDs and WeekendNDDs were collected face-to-face during regularly scheduled dialysis treatments, and WeekdayDD recalls were collected the day after dialysis via telephone. Recalls were structured using the Nutrition Data System for Research [NDSR] dietary analysis software program, described below.24 Recalls employed two-passes (i.e., a quick list with queries on commonly forgotten foods that appeared as prompts in NDSR, such as condiments, sweeteners, salt, seasonings, and added fats). Portion size was estimated using standard visual cues (e.g. 3 ounces of meat is equivalent in size to a deck of cards).

Recalls were entered into the NDSR dietary analysis software program.24 NDSR is comprehensive nutrient calculation software maintained by the Nutrition Coordinating Center at the University of Minnesota. It contains over 18,000 foods, 8,000 brand name products and a number of ethnic foods. Nutrient values are reported per 100 grams for each of 156 nutrients, nutrient ratios, and food components contained in the database. Additional health and sociodemographic data were obtained from a review of medical records and a sociodemographic questionnaire.

Analysis

Study participants were described in terms of health and sociodemographic characteristics. Calorie and protein intake were normalized to edema-free adjusted body weight (aBWef) as follows:25

aBWef=BWef+[(SBWBWef)*0.25]

where BWef = baseline dry weight (in kg) and SBW = standard body weight from NHANES II for gender, height and body frame size.

Dietary intake was described by day of the week and dialysis treatment (WeekdayNDDs WeekendNDDs, and WeekdayDD) in terms of total grams (gms) of food, vitamin and mineral content, calories, protein, and the proportion of sodium gms to total gms of food consumed. Nutrient values were compared by type of day using exact Friedman aligned rank tests, which standardize the within-participant comparisons across days. The association between total dietary sodium and total gms of food consumed was summarized using Spearman’s rank correlation coefficient. Concentration of dietary sodium (Na+) was defined as the ratio of total dietary sodium to total gms of food consumed during the day. P values of < 0.5 were considered statistically significant. Analyses were done using StatXact version 8.26

Results

Twenty-two individuals consented to the study and completed the baseline dietary assessment. Demographic and health characteristics of participants are shown in Table 1. Participants were middle-aged, predominantly minority and male, with a median duration of dialysis of 3.9 years and a median aBWef of 78.7 kg. Hypertension was the etiology of ESRD for 36.4% of participants.

Table 1.

Characteristics of Participants

Median (Q1–Q3)
Age (years) 55 (37–60)
Duration of dialysis (years) (n=21)* 3.9 (2.0–8.3)

aBWef (kg)(n=21)* 78.7 (68.1–92.3)

N (%)

Male 13 (59.1)
Minority race 17 (77.3)
Etiology of ESRD
  Hypertension 8 (36.4)
  Diabetes 5 (22.7)
  Glomerulonephritis 4 (18.2)
  Other 4 (18.2)
  Unknown 1 (4.6)
*

Denominators other than 22 (due to missing data) are noted.

Energy intake and protein are summarized by treatment and day of the week in Table 2. Participants consumed less food (a mean of 1,378.7 gms) on WeekdayDDs, compared to 1,614.4 gms on WeekdayNDDs and 1,560.4 gms on WeekendNDDs (p=0.19). Although no significant differences were seen by type of day, participants consumed at most 75% of the energy and protein recommended by the National Kidney Foundation for HD patients on all types of days.25

Table 2.

Volume, Energy, and Sodium Concentration by Day of the Week and Dialysis Treatment Status

Standardized calorie, protein, and
sodium intake
(recommended)
Weekday
Nondialysis Day
(n=22)
Weekday
Dialysis Day
(n=21)
Weekend
Nondialysis Day
(n=21)
Mean
(%)*
SD Mean
(%)*
SD Mean
(%)*
SD P-
value
Total grams of food consumed 1614.4 591.8 1378.7 544.7 1560.4 585.7 0.19
Calories kcal/ kg edema-free adjusted body weight/day 21.0 6.8 19.0 8.5 22.3 11.3 0.66
% of recommended calorie intake (30–35 kcal/kg/day)* (70.0) (63.3) (74.3)
Protein gm/ kg edema-free adjusted body weight/day 0.9 0.3 0.8 0.4 0.9 0.5 0.38
% of recommended protein intake (>1.2 g/kg/day)* (75.0) (66.6) (75.0)
Sodium concentration of foods consumed (mgs Na+/Total grams/day) 1.7 0.7 1.6 0.7 1.5 0.8 0.74
*

Based on nutritional recommendations established by K/DOQI. [5]

Based on 2 df exact Friedman aligned rank test

The concentration of sodium in foods consumed was similar on WeekdayNDDs (1.7 mgs/gm/day), WeekdayDDs (1.6 mgs/gm/day) and WeekendNDDs (1.5 mgs/gm/day), p=0.74; Table 2. Total dietary sodium was positively associated with total gms of food consumed on WeekdayDDs (rho = 0.44, p = 0.04) and.WeekendNDDs (rho = 0.73, p < 0.01; Figure 1).

Figure 1.

Figure 1

Scatter Plots of Total Dietary Sodium and Total gms of Food consumed, by Day of the Week and Dialysis Treatment Status

Micronutrient intake is summarized in relationship to treatment and day of the week in Table 3. Mean consumption of vitamin E differed significantly by type of day (p=0.03), and was highest (12.1 mg/day) on WeekdayNDDs. Mean vitamin intake was below the recommended minimum for Vitamins D, E, and pantothenic acid on all days, Vitamin C on WeekdayDDs, and folic acid on WeekdayDDs and WeekendNDDs.

Table 3.

Vitamin and Mineral Intake by Day of the Week and Dialysis Treatment Status

Vitamins and minerals
(recommended)
Weekday Nondialysis
Day
(n=22)
Weekday
Dialysis Day
(n=21)
Weekend Nondialysis
Day (n=21)
Mean SD Mean SD Mean SD P-value
Vitamins

Vitamin A (700–900 mcg/day)* 2118.7 4341.5 1616.6 1957.6 2385.1 2508.0 0.10
Vitamin D (5–15 mcg/day)* 3.4 2.6 3.2 3.4 3.4 3.3 0.85
Vitamin E (15 mg/day)* 12.1 15.4 8.8 14.9 7.4 7.9 0.03
Vitamin K (90–120 mcg/day)* 178.1 398.6 124.5 241.9 218.2 390.7 0.47
Vitamin C (75–90 mg/day)* 83.7 129.1 61.5 71.5 83.2 66.6 0.35
Thiamin (1.1–1.2 mg/day)* 1.4 0.7 1.2 0.6 1.4 0.8 0.30
Riboflavin (1.1–1.3 mg/day)* 1.6 0.7 1.4 0.8 1.7 1.1 0.65
Niacin (14–16 mg/day)* 19.7 9.3 16.5 7.8 18.0 9.8 0.40
Pantothenic acid (5 mg/day)* 4.4 2.3 3.3 1.9 3.5 1.7 0.08
Vitamin B6 (1.3–1.7 mg/day)* 1.6 0.8 1.3 0.8 1.4 0.8 0.39
Folic acid (400 mcg/day)* 410.5 383.4 320.1 212.5 347.4 185.3 0.48
Vitamin B12 (2.4 mcg/day)* 3.6 2.2 3.6 2.4 4.2 3.7 0.78

Minerals

Calcium (<2,000 mg/day including binders)*** 737.3 624.7 589.8 449.2 773.3 569.3 0.05
Phosphorus (<1,000 mg/day)*** 891.2 269.8 761.9 385.6 977.9 588.9 0.45
Iron (8–18 mg/day)* 13.5 7.2 11.8 7.0 14.1 8.0 0.30
Potassium (2000–3000mg/day)** 1927.3 839.0 1643.6 967.2 1777.8 947.9 0.59
Magnesium (200–300 mg/day)*** 201.0 80.6 173.2 96.5 195.4 103.5 0.40
Zinc (15 mg/day)** 11.2 5.8 8.7 5.0 9.8 7.4 0.65
Selenium (55 mcg/day)* 102.2 36.9 76.5 36.3 99.7 61.2 0.09
Sodium (<2,000 mg/day)+ 2632.8 985.8 2052.9 1010.4 2608.4 1355.4 0.05
*

Based on the Dietary Reference Intakes established by the National Academy of Sciences. Institute of Medicine. Food and Nutrition Board [71}

**

From Kopple JD and Massry SG. [72]

***

From NKD KDOQI Clinical Practice Guidelines [1]

+

From NKF KDOQI Clinical Practice Guidelines [4]

Based on 2 df exact Friedman aligned rank test

Calcium and sodium consumption differed by type of day (p=0.05 for each), with relatively lower mean consumption of these minerals on WeekdayDDs (Table 3). On all three types of days, mean sodium levels exceeded 2,000 mg, and intake of zinc was below the recommended level of 15 mg/day. On Weekday DDs and Weekend NDDs, magnesium intake was below the recommended amount of 200–300 mg/day.

Discussion

Intake of calories and protein was considerably less than the recommended levels for hemodialysis patients while sodium intake was high in this small sample of in-center HD patients. In addition, several vitamins and zinc was less than the recommended dietary intake for adults. Given the small sample and the large standard deviations observed, the lack of significance differences across treatment and day of the week is not surprising. These data suggest some patterns that merit further investigation.

Although the findings of low energy and protein intake in this study are not significantly different there is a trend of lower intake on dialysis days. These findings are consistent with those of other investigations of HD1720,2728 and peritoneal dialysis.29 That food volume, energy and protein intake were lowest on dialysis treatment days is consistent with the findings of Dassanayake et al.19 and Burrowes et al.17 Lower intake on dialysis days may be the result of a disrupted meal schedule.16 The dialysis units from which we recruited participants for this pilot study, by routine, did not permit patients to eat during treatments. Given that many hemodialysis patients are likely to have an inadequate dietary intake on dialysis days and the prevalence of malnutrition in this population, interventions to promote improved intake on these days should be explored.

Dietary protein has long been the cornerstone of the renal diet. During the early years of hemodialysis, protein was restricted in order to minimize the accumulation of urea between dialysis treatments. From 1960 through the late 1970’s recommendations for protein intake ranged from 0.5–0.8 gm/kg. As it became evident that dialysis patients with a restricted protein intake were at greater risk of malnutrition, the recommended protein intake increased in the early 1980’s to 1.0 gm/kg and in 2000 to the current 1.2 gm/kg.25,3033 In 1990, Lowrie and Lew showed that inadequate protein intake, reflected in, a low nPCR and low serum albumin levels, was associated with an increased relative risk of death.34 Consequently, more attention has been paid in recent years to assuring the adequacy of dietary protein, and the consumption of nutritionally dense foods. Although an increased dietary protein intake is recommended for patients on hemodialysis, an increased protein intake may also result in an increased intake of phosphorus and consequent vascular calcification. Therefore, patients who are counseled to increase protein intake should be counseled on adherence to binders as well. Data from the Dialysis Outcomes and Practice Patterns Study indicate that less than half of dialysis patients meet target values for serum phosphorus levels, and nonadherence to phosphate binders is likely to be partially responsible.35 In a recent small study, Lindberg and Lindberg identified the following barriers to phosphate binder adherence: objectionable taste, the large size of the pills, nausea after ingestion, forgetfulness, the need to take numerous other medications, and ignorance regarding the importance of taking binders with each meal. Lindberg and Lindberg suggest addressing nonadherence with patient education, routine assessment of the acceptability of the prescribed binder, and trials of alternative binders when possible.36 When phosphatemia is not controlled through dietary restriction, counseling to enhance adherence to phosphorus binders will be necessary. Longer or more frequent HD also may be helpful, although this option is not always available or well received by many patients.

In spite of consuming a lower volume of food on WeekdayDDs than either WeekdayNDDs or WeekendNDDs, participants still consumed a significant amount of sodium. Our clinical experience suggests that, due to the need to accommodate lengthy treatments and the fatigue often experienced after dialysis, HD patients often rely on higher sodium fast foods and convenience foods. Because participants consumed the least amount of food, calories, and protein on dialysis days, we expected that poorer appetite on dialysis days would result in participants consuming higher total Na+ and foods with higher Na+ concentrations (i.e., evidence of consuming snack foods rather than regular meals). Although the difference was not statistically significant, we were surprised that the highest concentration of Na+ actually was consumed on WeekdayNDDs and the least concentration consumed on WeekdayDDs. It is possible that the physiologic response to dialysis resulted in Na+ seeking behavior on WeekdayNDDs. Additional research with a larger sample would be needed to confirm these observations.

For the vitamin and mineral deficits noted in our study, Table 4 lists the common sources of those nutrients and the reasons that they are restricted in HD patients. Given the limited nature of the HD diet, the deficits in vitamin and mineral intake should not be surprising. Of interest is the low dietary intake of pantothenic acid, a vitamin which is widely distributed in foods. Rich sources of pantothenic acid include liver, egg yolk, chicken, yogurt, milk legumes, broccoli, avocado, and sweet potatoes. Most of these foods are high in potassium and phosphorus and therefore limited on a renal diet which may explain in part the low pantothenic acid levels. In addition, some good sources of pantothenic acid are also sources of high biological protein of which many patients do not consume enough.

Table 4.

Possible Reasons for Dietary Deficits in Hemodialysis Patients

Deficits noted Dietary sources commonly used
to address deficits*
Rationale for limiting these
foods in HD

High
Potassium**
High
Phosphorus**

Vitamin D Dairy products X X

Vitamin E Milk, nuts, seeds, X X
Whole grains X
Leafy green vegetables X

Vitamin C Oranges and orange juice, tomatoes, broccoli, brussel sprouts, leafy greens, winter squash, sweet and white potatoes, X

Pantothenic acid Whole grains X
Legumes X X

Folic acid Leafy green vegetables X
Legumes, sunflower seeds X X

Magnesium Green vegetables X
Legumes X X
Dairy products X X

Zinc Dairy products, peanuts, beans, and pumpkin seeds X X
Whole grains X
Potatoes X
*

United States Department of Agriculture. Agricultural Research Service.

National Nutrient Database for Standard Reference, Release 22 [73]

**

National Renal Diet. A Healthy Food Guide for People on Dialysis/Renal Dietitians Dietetic Practice Group of the American Dietetic Association 2nd ed. [74]

Several of the deficits suggested by our data are of particular importance in the HD patient population. Investigators have recently demonstrated wash-out of water-soluble B vitamins with hemodialysis.37 Loss of appetite, nausea, vomiting, and/or diarrhea have been associated with deficits in folate38 and zinc.39 Fatigue and muscle weakness, common complaints voiced by HD patients,4041 are associated with deficits in vitamins C42 and D.43 Problems with cognitive function and mental clarity are more common in HD patients than in the normal population who are not on dialysis,44 and may be influenced by dietary intake of folate4546 and zinc.47 HD, patients are prone to defective bone mineralization, which also is associated with vitamin D deficiency.48 Uncontrolled hypertension may be influenced by vitamin D.49 The primary cause of death in HD patients is cardiovascular disease,50 which may be associated with deficits in pantothenic acid and vitamin C.46,51 Reduced vitamin C, E, and folate have been associated with chronic inflammation,5254 which is another significant problem in HD patients.55 The response of dialysis patients to erythropoietin is diminished when anemia is accompanied by a folate deficiency.56 Although intake low intake of magnesium observed in this study is not desirable HD patients typically have a positive magnesium balance57 and magnesium supplements are usually not recommended.

As discussed below, caution must be used in drawing firm conclusions about dietary deficits from these data. Prior to taking any action to address dietary deficits, it is important to consider the extent to which biochemical and physical assessments confirm the manifestation of mineral and vitamin deficiencies, as well as the extent to which the patient is prescribed appropriate dietary supplements. Where clear deficits exist, there are a few practical steps that could be taken to address them. Although dialysis patients cannot consume them in unlimited quantities, green peppers, cauliflower, cabbage, watermelon, strawberries, raspberries, blueberries, cranberries, and pineapples all are good sources of Vitamin C (and also contain limited amounts of potassium). Fatty fishes such as salmon, mackerel, and tuna are a good source of vitamin D, and eggs and meat are good sources of pantothenic acid. Protein-rich foods such as beef, lamb, pork, crabmeat, turkey, chicken, lobster, clams and salmon are the best sources of zinc. Again, patients who are encouraged to consume greater quantities of these high phosphorus foods should also be encouraged to take their binders.

HD patients typically are prescribed several nutritional supplements, including active vitamin D and iron (both often given intravenously), vitamins with B and C content, and sometimes protein supplements. However, supplementation with 25 OH vitamin D and zinc is not standard practice, and future research is needed to evaluate their benefits in HD patients. In the meantime, the healthcare team may wish to consider measuring zinc and 25 OH vitamin D levels in HD patients to assess the need for replacement.

With the new Medicare reimbursement guidelines, programs are likely to move away from administration of medications intravenously on HD, and move toward oral prescriptions. However, adherence to oral medication regimens is poor,5961 and inversely associated with the regimen complexity that is typical of the HD medication regimen.6264 Furthermore, adherence of chronically ill people to their medication regimen drops dramatically after 6 months.65 We found no evidence from the literature to suggest that adherence to nutritional supplements is better than adherence to conventional medications. Intervention approaches that are modestly effective in enhancing medication adherence may be useful for encouraging patients to take nutritional supplements. In particular, using pillboxes, involving family caregivers, pairing nutritional supplements with habitual behaviors (such as brushing teeth), cuing (e.g. use of alarms, and placing supplements in a visible location), positive reinforcement, and didactic education may facilitate adherence.6567

Because of the pilot nature of the study, there are several limitations that preclude firm clinical or research implications. In particular the the results reported here were derived from statistical analyses of numerical data derived from the NDS-R. Additional qualitative research would be useful for characterizing the nature of dietary intake and developing specific dietary counseling approaches. Also, the data were derived from a small sample which is likely to be underpowered to detect differences in intake by day of the week for many of the nutrients evaluated. The sample was drawn from 2 dialysis centers in the Pittsburgh area, limiting generalizability of the findings.

Additionally, with the goals of minimizing measurement burden and retaining this sample through a 16-week intervention study, the investigators used a measurement protocol that could compromise the precision of nutritional estimates. Other researchers have found that more than three recalls are required to adequately capture dietary variability.6869 To minimize memory bias, dietary recalls using a 5-step (rather than 2-step) multiple pass system are recommended.70 To minimize measurement error, the collection of recalls using the same approach (rather than a combination of face-to-face and telephone) would be advised.

Conclusion

Data from this small pilot study found few differences in nutritional intake by dialysis treatment day and day of the week. The data suggest poor intake of calories, protein, and several vitamins and minerals, as well as excess sodium consumption. However, because of sampling and measurement limitations, caution must be used in drawing conclusions about the nature of the diet consumed by hemodialysis patients. Additional research is needed.

Acknowledgements

This study was supported through grants from the Paul Teschan Research Fund and NIH-R01-NR010135. The authors would like to acknowledge Dialysis Clinics Inc. as well as the individual contributions of: Rita Marsh, RN, MSN; Deborah Klinvex, BA; and Tienna Luster. The contents of this article do not represent the views of the Department of Veterans Affairs of the United States Government.

References

  • 1.National Kidney Foundation. KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202. [PubMed] [Google Scholar]
  • 2.National Kidney Foundation. KDOQI Clinical Practice Guidelines and clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(suppl 2):S1–S180. doi: 10.1053/j.ajkd.2006.12.005. [DOI] [PubMed] [Google Scholar]
  • 3.National Kidney Foundation. KDOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41(suppl 3):S1–S92. [Google Scholar]
  • 4.National Kidney Foundation. KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004;43(suppl 1):S1–S290. [PubMed] [Google Scholar]
  • 5.National Kidney Foundation. KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis. 2000;35(suppl 2):S1–S140. doi: 10.1053/ajkd.2000.v35.aajkd03517. [DOI] [PubMed] [Google Scholar]
  • 6.D’Amico M, Locatelli F. Hypertension in dialysis: pathophysiology and treatment. J Nephrol. 2002;15(4):438–445. [PubMed] [Google Scholar]
  • 7.Salem MM. Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis. 1995;26(3):461–468. doi: 10.1016/0272-6386(95)90492-1. [DOI] [PubMed] [Google Scholar]
  • 8.Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK, et al. for the HEMO Study Group. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol. 2001;21(4):280–288. doi: 10.1159/000046262. [DOI] [PubMed] [Google Scholar]
  • 9.Agarwal R. Strategies and feasibility of hypertension control in a prevalent hemodialysis cohort. Clin Nephrol. 2000;53(5):344–353. [PubMed] [Google Scholar]
  • 10.Klassen PS, Lowrie EG, Reddan DN, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. J Am Med Assoc. 2002;287(12):1548–1555. doi: 10.1001/jama.287.12.1548. [DOI] [PubMed] [Google Scholar]
  • 11.Kursat S, Ozgur B, Alici T. Effect of ultrafiltration on blood pressure variability in hemodialysis patients. Clin Nephrol. 2003;59(4):289–292. doi: 10.5414/cnp59289. [DOI] [PubMed] [Google Scholar]
  • 12.Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens. 2001;10(5):563–568. doi: 10.1097/00041552-200109000-00003. [DOI] [PubMed] [Google Scholar]
  • 13.Navarro JA, Granadillo VA, Salgado O, et al. Bone metal content in patients with chronic renal failure. Clin Chim Acta. 1992;211(3):133–142. doi: 10.1016/0009-8981(92)90189-w. [DOI] [PubMed] [Google Scholar]
  • 14.Tzamaloukas AH, Avasthi PS. Temporal profile of serum potassium concentration in nondiabeteic and diabetic outpatients on chronic dialysis. Am J Nephrol. 1987;7(2):101–109. doi: 10.1159/000167443. [DOI] [PubMed] [Google Scholar]
  • 15.Sacchette A, Stucco N, Ambiance P, Torres M. ED hemodialysis for treatment of renal failure emergencies. Am J Emerge Med. 1999;17(3):305–307. doi: 10.1016/s0735-6757(99)90131-6. [DOI] [PubMed] [Google Scholar]
  • 16.Labile M, Fuqua D. Nutritional aspects in hemodialysis. Kidney Int. 2000;76:S133–S139. doi: 10.1046/j.1523-1755.2000.07617.x. [DOI] [PubMed] [Google Scholar]
  • 17.Burrowes JD, Larine B, Cochran DB, et al. for the HEMO Study Group. Effects of Dietary Intake, Appetite, and Eating Habits on Dialysis and Non-Dialysis Treatment Days in Hemodialysis Patients: Cross-Sectional Results from the HEMO Study. J Ran Nutr. 2003;13(3):191–198. doi: 10.1016/s1051-2276(03)00069-4. [DOI] [PubMed] [Google Scholar]
  • 18.Bossily M, Muscaritoli M, Tizzy L, et al. Variables associated with reduced dietary intake in hemodialysis patients. J Ran Nutr. 2005;15(2):244–252. doi: 10.1053/j.jrn.2005.01.004. [DOI] [PubMed] [Google Scholar]
  • 19.Dassanayake T, Kazempour-Ardebili S, Lecamwasam V, et al. A pilot study investigating differences in food consumption and blood glucose profiles in diabetic haemodialysis patients on dialysis days compared to nondialysis days. J Ran Nutr. 2008;18(3):S7. [Google Scholar]
  • 20.Sharma M, Rao M, Jacob S, Jacob CK. A dietary survey in Indian hemodialysis patients. J Ren Nutr. 1999;9(1):21–25. doi: 10.1016/s1051-2276(99)90018-3. [DOI] [PubMed] [Google Scholar]
  • 21.Sevick MA, Stone RA, Novak M, et al. A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient: a case study. Patient Preference and Adherence. 2008;2(1):177–184. [PMC free article] [PubMed] [Google Scholar]
  • 22.Bandura A. Self-Efficacy: The Exercise of Control. New York: Freeman and Co; 1997. [Google Scholar]
  • 23.Sehgal AR, Grey SF, DeOreo PB, et al. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997;30(1):41–49. doi: 10.1016/s0272-6386(97)90563-1. [DOI] [PubMed] [Google Scholar]
  • 24.University of Minnesota Nutrition Coordinating Center. [Accessed June 9, 2009];Nutrition Data System for Research. http://www.ncc.umn.edu/products/ndsr.html. [Google Scholar]
  • 25.Kopple JD. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis. 2001;37(1):S66–S70. doi: 10.1053/ajkd.2001.20748. [DOI] [PubMed] [Google Scholar]
  • 26.Cytel Inc. StatXact 8. Cambridge: Cytel Inc; 2007. [Google Scholar]
  • 27.Lou LM, Campos B, Gimeno JA, Caverni A, Boned B. Main dietary intake deficits in hemodialysis patients: approach to a healthy dietary model based on the Mediterranean diet. Nefrologia. 2007;27(1):38–45. [PubMed] [Google Scholar]
  • 28.Moreira AC, Miguel T, Gaspar A, Simoes J. Dietary intake deficiency in hemodialysis patients. J Ren Nutr. 2008;18(3):S7. [Google Scholar]
  • 29.Wright M, Woodrow G, O’Brien S, et al. Disturbed appetite patterns and nutrient intake in peritoneal dialysis patients. Perit Dial Int. 2003;23(6):550–556. [PubMed] [Google Scholar]
  • 30.Mitchell MC, Smith EJ. Dietary Care of the Patient with Chronic Oliguria. Am J Clin Nutr. 1966;19(3):163–169. doi: 10.1093/ajcn/19.3.163. [DOI] [PubMed] [Google Scholar]
  • 31.Cullen AB. Dietary Management of Chronic Uremia and Patient Adherence to Dietary Restrictions. Am J Clin Nutr. 1968;21(6):626–630. doi: 10.1093/ajcn/21.6.626. [DOI] [PubMed] [Google Scholar]
  • 32.Burton BT. Current concepts of nutrition and diet in diseases of the kidney. J Am Diet Assoc. 1974;65(6):623–626. [PubMed] [Google Scholar]
  • 33.Harvey KB, Blumenkrantz MJ, Levine SE, Blackburn GL. Nutritional assessment and treatment of chronic renal failure. Am J Clin Nutr. 1980;33(7):1586–1597. doi: 10.1093/ajcn/33.7.1586. [DOI] [PubMed] [Google Scholar]
  • 34.Lowrie EG, Lew NL. Death Risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15(5):458–482. doi: 10.1016/s0272-6386(12)70364-5. [DOI] [PubMed] [Google Scholar]
  • 35.Young EW, Akiba T, Albert JM, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis. 2004;44(5):S34–S38. doi: 10.1053/j.ajkd.2004.08.009. [DOI] [PubMed] [Google Scholar]
  • 36.Lindberg M, Lindberg P. Overcoming obstacles for adherence to phosphate binding medication in dialysis patients: a qualitative study. Pharm World Sci. 2008;30(5):571–576. doi: 10.1007/s11096-008-9212-9. [DOI] [PubMed] [Google Scholar]
  • 37.Heinz J, Domrose U, Westphal S, Luley C, Neumann KH, Dierkes J. Washout of water-soluble vitamins and of homocysteine during haemodialysis: Effect of high-flux and low-flux dialyzer membranes. Nephrology. 2008;13(5):384–389. doi: 10.1111/j.1440-1797.2008.00946.x. [DOI] [PubMed] [Google Scholar]
  • 38. [Accessed April 15, 2009]; http://ods.od.nih/factsheets/folate.asp. [Google Scholar]
  • 39. [Accessed April 15, 2009]; http://ods.od.nih/factsheets/zinc.asp. [Google Scholar]
  • 40.Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis. 2008;52(2):353–365. doi: 10.1053/j.ajkd.2008.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Fahal IH, Bell GM, Bone JM, et al. Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant. 1997;12(1):119–127. doi: 10.1093/ndt/12.1.119. [DOI] [PubMed] [Google Scholar]
  • 42.Johnston CS, Corte C. Tissue carnitine fluxes in vitamin C depleted-repleted guinea pigs. J Nutr Biochem. 1999;10(12):696–699. doi: 10.1016/s0955-2863(99)00057-1. [DOI] [PubMed] [Google Scholar]
  • 43.Venning G. Recent developments in Vitamin D deficiency and muscle weakness among elderly people. Br Med J. 2009;330(7490):524–526. doi: 10.1136/bmj.330.7490.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67(2):216–223. doi: 10.1212/01.wnl.0000225182.15532.40. [DOI] [PubMed] [Google Scholar]
  • 45.Rosenberg IH, Miller JW. Nutritional factors in physical and cognitive functions of elderly people. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr. 1992;55(6):1237S–1243S. doi: 10.1093/ajcn/55.6.1237S. [DOI] [PubMed] [Google Scholar]
  • 46.Rampersaud GC,RD, Kauwell GPA, Bailey LB. Folate: A Key to Optimizing Health and Reducing Disease Risk in the Elderly. J Am Coll Nutr. 2003;22(1):1–8. doi: 10.1080/07315724.2003.10719270. [DOI] [PubMed] [Google Scholar]
  • 47.Maylor EA, Simpson EE, Secker DL, et al. Effects of zinc supplementation on cognitive function in healthy middle-aged and older adults: the ZENITH study. Br J Nutr. 2006;96(4):752–760. [PubMed] [Google Scholar]
  • 48.Scharla S. Diagnosis of disorders of vitamin D-metabolism and osteomalacia. Clin Lab. 2008;54(11–12):451–459. [PubMed] [Google Scholar]
  • 49.Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52(5):828–832. doi: 10.1161/HYPERTENSIONAHA.108.117630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.USRDS Annual Data Report. [Accessed May 1, 2009];Chapter 6: Morbidity and Mortality. http://www.usrds.org/2008/view/esrd_06.asp. [Google Scholar]
  • 51.Siow RCM, Richards JP, Pedley KC, Leak DS, Mann GE. Vitamin C Protects Human Vascular Smooth Muscle Cells Against Apoptosis Induced by Moderately Oxidized LDL Containing High Levels of Lipid Hydroperoxides. Arterioscler Thromb Vasc Biol. 1999;19(10):2387–2394. doi: 10.1161/01.atv.19.10.2387. [DOI] [PubMed] [Google Scholar]
  • 52.Perier C, Triouleyre P, Terrat C, Chomette MC, Beauchet O, Gonthier R. Energy and nutrient intake of elderly hospitalized patients in a steady metabolic status versus catabolic status. J Nutr Health Aging. 2004;8(6):518–520. [PubMed] [Google Scholar]
  • 53.Kuhlmann MK, Levin NW. Interaction between nutrition and inflammation in hemodialysis patients. Contrib Nephrol. 2005;149:200–207. doi: 10.1159/000085540. [DOI] [PubMed] [Google Scholar]
  • 54.Singh U, Devaraj S. Vitamin E: Inflammation and Atherosclerosis. Vitamins & Hormones. 2007;76:519–549. doi: 10.1016/S0083-6729(07)76020-X. [DOI] [PubMed] [Google Scholar]
  • 55.de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW for the NECOSAD Study Group. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant. 2008;23(9):2957–2964. doi: 10.1093/ndt/gfn167. [DOI] [PubMed] [Google Scholar]
  • 56.Humphries JE. Anemia of renal failure. Use of erythropoietin. Med Clin North Am. 1992;76(3):711–725. doi: 10.1016/s0025-7125(16)30349-2. [DOI] [PubMed] [Google Scholar]
  • 57.Contiguglia SR, Alfrey AC, Miller N, Butkus D. Total body magnesium excess in chronic renal failure. Lancet. 1972;1(7764):1300–1302. doi: 10.1016/s0140-6736(72)91032-x. [DOI] [PubMed] [Google Scholar]
  • 58.Kopple JD, Massry SG. Nutritional Management of Renal Diseases. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 296. [Google Scholar]
  • 59.Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ter. 2001;23(8):1296–1310. doi: 10.1016/s0149-2918(01)80109-0. [DOI] [PubMed] [Google Scholar]
  • 60.DiMatteo MR. Variations in Patients’ Adherence to Medical Recommendation: A Quantitative Review of 50 Years of Research. Med Care. 2004;42(3):200–209. doi: 10.1097/01.mlr.0000114908.90348.f9. [DOI] [PubMed] [Google Scholar]
  • 61.Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J for the VA Naltrexone Study Group 425. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6(5):566–573. doi: 10.1046/j.1524-4733.2003.65269.x. [DOI] [PubMed] [Google Scholar]
  • 62.Cramer JA. A systematic Review of Adherence With Medications for Diabetes. Diabetes Care. 2004;27:1218–1224. doi: 10.2337/diacare.27.5.1218. [DOI] [PubMed] [Google Scholar]
  • 63.Dezji CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care. 2000;9(9):2–6. [PubMed] [Google Scholar]
  • 64.Andrejak M, Genes N, Vaur L, et al. Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: a comparison of once daily versus twice daily regimen. Am J Hypertens. 2000;13(2):184–190. doi: 10.1016/s0895-7061(99)00175-2. [DOI] [PubMed] [Google Scholar]
  • 65.Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med. 2005;353(5):487–497. doi: 10.1056/NEJMra050100. [DOI] [PubMed] [Google Scholar]
  • 66.Peterson AM, Takiya L, Finley R. Meta-Analysis of Trials of Interventions to Improve Medication Adherence. Am J Health-Syst Pharm. 2003;60(7):657–665. doi: 10.1093/ajhp/60.7.657. [DOI] [PubMed] [Google Scholar]
  • 67.McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: Scientific review. J Am Med Assoc. 2002;288(22):2868–2879. doi: 10.1001/jama.288.22.2868. [DOI] [PubMed] [Google Scholar]
  • 68.Basiotis PP, Welsh SO, Cronin FJ, Kelsay JL, Mertz W. Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence. J Nutr. 1987;117(9):1638–1641. doi: 10.1093/jn/117.9.1638. [DOI] [PubMed] [Google Scholar]
  • 69.Mennen LI, Bertrais S, Galan P, Arnault N, Potier de Couray G, Hercberg S. The use of computerized 24h dietary recalls in the French SU.VI.MAX Study: number of recalls required. Eur J Clin Nutr. 2002;56(7):659–665. doi: 10.1038/sj.ejcn.1601374. [DOI] [PubMed] [Google Scholar]
  • 70.Conway JM, Ingwersen LA, Moshfegh AJ. Accuracy of Dietary Recall Using the USDA Five-Step Multiple Pass Method in Men: A Observational Validation Study. J Am Diet Assoc. 2004;104(4):595–603. doi: 10.1016/j.jada.2004.01.007. [DOI] [PubMed] [Google Scholar]
  • 71.Dietary Reference Intakes. Recommended Intakes for Individuals. [Accessed July 26, 2010];National Academy of Sciences. Institute of Medicine. Food and Nutrition Board. 2004 http://fnic.nal.usda.gov/nal_display/index.php?info_center=4&tax_level=3&tax_subject=256&topic_id=1342&level3_id=5140. [Google Scholar]
  • 72.Kopple JD, Massry SG. Nutritional Management of Renal Disease. 2nd ed. Philadelphia ,PA: Lippincott Williams & Wilkins; 2004. [Google Scholar]
  • 73.United States Department of Agriculture. Agricultural Research Service. [Accessed July 26, 2010];National Nutrient Database for Standard Reference. Release 22. http://www.ars.usda.gov/Services/docs.htm?docid=18877.
  • 74.National Renal Diet. A Healthy Food Guide for People on Dialysis/Renal Dietitians Dietetic Practice Group of the American Dietetic Association 2nd ed [Google Scholar]

RESOURCES